Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Fremanezumab for Migraine Prevention: Interim Analysis of the Non-Interventional FINESSE Study

Author:Straube, Andreas   Brössner, Gregor   Gaul, Charly   Hamann, Xenia   Kraya, Torsten   Schauerte, Isabel   Neeb, Lars   

Session Name:P13: Headache: Towards Precision Medicine 3  

Topic:Headache  

Program Number:P13.010  

Author Institution:Ludwig-Maximilians-University Munich, Munich, Germany  Medical University of Innsbruck, Innsbruck, Austria  Headache Center Frankfurt, Frankfurt am Main, Germany  Teva GmbH, Ulm, Germany  St. Georg Hospital/ Headache Center Halle, Leipzig, Germany  Institut Dr. Schauerte, Munich, Germany  Department of Neurology, Charité Universitätsmedizin Berlin/Helios Global Health Berlin  

Intrajejunal Levodopa Infusion for Parkinson's Disease over 11 years: A Canadian Experience

Author:VEKHANDE, Chetan   Hamed, Moath   Tremain, Genise   Mah, Jennifer   Shetty, Aakash   Lazarescu, Adriana   Suchowersky, Oksana   

Session Name:P13: Movement Disorders: Non Surgical Therapeutics in Parkinson's Disease 1  

Topic:Movement Disorders  

Program Number:P13.014  

Author Institution:University of Alberta, Edmonton, AB, Canada  Weill Cornell Medicine, Brooklyn, NY  Alberta Health Services, Edmonton, AB, Canada  

Change In Fall Risk-Increasing Drug Use Among Individuals with Parkinson Disease Before and After a Serious Injury

Author:Pham Nguyen, Thanh Phuong   Gray, Shelly L   Newcomb, Craig   Liu, Qing   Hamedani, Ali G   Hennessy, Sean   Willis, Allison W   

Session Name:P2: Neuroepidemiology 2  

Topic:Neuroepidemiology  

Program Number:P2.032  

Author Institution:University of Pennsylvania Perelman School of Medicine, Philadelphia, PA  University of Washington, Seattle, WA  

Results from a 36-Week Open-Label Study of Recombinant Human Growth Hormone and Testosterone in Facioscapulohumeral Muscular Dystrophy (FSHD)

Author:Heatwole, Chad   Luebbe, Elizabeth   Hamel, Johanna   Mongiovi, Philip   Ciafaloni, Emma   Dilek, Nuran   Martens, William   Weber, David   Hani, Rashid   Allen, Jamie   Smith, Claire   Howell, Samantha   Rosero, Spencer   Eichinger, Katy   Baker, Linday   Dekdebrun, Jeanne   Hilbert, Jim   Varma, Anika   McDermott, Michael   Thornton, Charles   Moxley, Richard   

Session Name:S48: Therapeutics for Muscle Disease  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S48.009  

Author Institution:University of Rochester Medical Center, Rochester, NY  Children's Hospital of Philadelphia, Philadelphia, PA  University of Rochester Medical Center, Baltimore, MD  

Most Opticospinal Demyelination is NMOSD, not MS- A 17-year UK Longitudinal Cohort Study

Author:Forcadela, Mirasol   Rocchi, Chiara   Panicker, Jay   Mutch, Kerry   Huda, Saif   Jacob, Anu   Hamid, Shahd   

Session Name:P5: MS Prognosis/Epidemiology  

Topic:MS and Inflammatory Disease  

Program Number:P5.003  

Author Institution:The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom